Navigation Links
FDA warns against the use of products that claim to treat erectile dysfunction

The U.S Food and Drug administration has issued a warning to consumers to stay away from products touted as succors for sexual problems, allegedly capable of enhancing// the sexual experience. According to the FDA, these products contain many harmful elements, which may trigger a host of health complications.

The harmful products doing the rounds are Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx and 4EVERON.

FDA has cautioned consumers, even senior citizens, who are already on these products to discontinue consumption and seek the advice of a medical specialist. Dr. Steven Galson, Director of FDA's Center for Drug Evaluation and Research said, "These products threaten the public health because they contain undeclared chemicals that are similar or identical to the active ingredients used in several FDA-approved prescription drug products. This risk is even more serious because consumers may not know that these ingredients can interact with medications and dangerously lower their blood pressure."


'"/>




Page: 1

Related medicine news :

1. International community warns India on HIV situation
2. Thakur warns doctors
3. Indian Government warns Gujarat regarding possibility of bird flu
4. Russia warns against travel to Turkey, Iran closes border
5. WHO warns that Asia is at high risk of Bird flu
6. A&E departments To Be Shut Down warns NHS chief
7. Stern Action will be Taken Against AIIMS Coterie warns Ramadoss
8. Stern action against AIIMS Medicos, warns Ramadoss
9. Maharashtra warns against Mahims miracle water
10. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
11. Man against HIV – new vaccine ready for human trials
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 24, 2017 , ... ... of a new report from the Frank Hawkins Kenan Institute of Private ... business leaders, academics and policy makers identified concrete solutions at the “What’s Next, ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a ... (NMIs) and co-funded by the European Union (EU), was completed in May 2015. The ... instead being maintained and used in air, which presents some challenges to establishing traceability ...
(Date:1/24/2017)... ... 2017 , ... A yellow fever outbreak in Brazil has infected over 100 ... primarily spread through contact with infected mosquitos. The outbreak has sparked increased concern about ... , According to multiple health organizations, the best way to prevent yellow fever is ...
(Date:1/24/2017)... ... ... “Who Would Have Dreamed: A Novel of Miracles”: a beautiful and poignant glimpse into ... purpose in her life. “Who Would Have Dreamed: A Novel of Miracles” is the creation ... writing. , Sharon shares that she started her spiritual journey later in life, ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... by patient survivors, today announced formation of its first global advisory board ... initiatives. , Like HCP founders, the global advisory board is composed ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... DIEGO , Jan. 24, 2017 ... in clinical materials management services, is pleased to ... of Operations. Kevin joins the Sherpa team to ... the highest level of service excellence. ... chain and pharmaceutical manufacturing industries. He has extensive ...
(Date:1/24/2017)... BERWYN, Pa. , Jan. 24, 2017 /PRNewswire/ ... Phase 2 biopharmaceutical company developing novel therapies for ... diseases, today announced the appointment of four world-class ... (SAB). These new appointments join QR Pharma,s previous ... strategic leadership and direction to support the development ...
(Date:1/24/2017)... FRANCISCO , January 24, 2017 The global  ... USD 239.8 billion by 2025, based on a new report by Grand ... cancer is projected to drive the market over the forecast period. Advancements ... are also estimated to boost growth.  Continue ... ...
Breaking Medicine Technology: